FINISHED DOSAGE FORMULATIONS
SORBITAN MONOLAURATE
Route : INTRAMUSCULAR
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 1.23
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : OPHTHALMIC
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 0.08
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 2.5
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 66.7
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : ORAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 83.9
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : TOPICAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 4.74
Potency Unit : %W/W

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SORBITAN MONOLAURATE
Route : TOPICAL
CAS : 1338-39-2
UNII : 6W9PS8B71J
Potency Amount : 4.74
Potency Unit : %W/W

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE